IMMUNECHO

Welcome to the Brand page for “IMMUNECHO”, which is offered here for Vaccines; vaccine adjuvants; medical, biological, and pharmaceutical preparations for medical use, preparations containing messenger rna for preventing and treating viruses and respiratory disorders; mrna-based therapeutics and therapeutic agents for in vivo, ex vivo, or in situ prevention and treatment of viruses and respiratory disorders; lipid nanoparticles for pharmaceutical, medical or diagnostic purposes; drug carriers for medical use, lipid nanoparticles for delivering drugs; lipid nanoparticles for drug delivery sold as an integral component of drugs; pharmaceutical preparations, messenger rna and delivery agents comprised of lipid nanoparticle carriers and polymers for the delivery of mrna to human cells;immune echo;medical, biological, and pharmaceutical preparations for scientific, research, medical laboratory use, or for the manufacture of pharmaceuticals, preparations containing messenger rna for preventing and treating viruses and respiratory disorders; biochemicals for in vivo, ex vivo, on vivo or in vitro scientific research and medical research, for use in the manufacture of pharmaceuticals for preventing and treating viruses and respiratory disorders; lipid nanoparticles for scientific, laboratory or medical research use;medical services; medical information; providing a website featuring medical information;pharmaceutical research and development; medical research services; biotechnology research; scientific research for medical purposes; design and development of medical technology; design, engineering, research, and development services in the field of nucleic acid sciences for medical and scientific applications; providing medical and scientific research in the fields of pharmaceuticals and vaccines;.

Its status is currently believed to be active. Its class is unavailable. “IMMUNECHO” is believed to be currently owned by “Seqirus Inc.”


Competing brands in the market may differentiate themselves from IMMUNECHO by offering different combinations of vaccines, adjuvants, and medical preparations. They might focus on targeting specific viruses or respiratory disorders, use different delivery mechanisms, or prioritize different aspects of immune system response enhancement.IMMUNECHO stands out for its offerings of messenger RNA-based therapeutics and lipid nanoparticles for preventing and treating viruses and respiratory disorders. This brand emphasizes cutting-edge technology and research in the field of medical and pharmaceutical preparations, showcasing a commitment to innovation and staying at the forefront of medical advancements.IMMUNECHO - Seqirus Inc.
Owner:
SEQIRUS INC.
Owner Details
Description:
Vaccines; vaccine adjuvants; medical, biological, and pharmaceutical preparations for medical use, preparations containing messenger RNA for preventing and treating viruses and respiratory disorders; mRNA-based therapeutics and therapeutic agents for in vivo, ex vivo, or in situ prevention and treatment of viruses and respiratory disorders; lipid nanoparticles for pharmaceutical, medical or diagnostic purposes; drug carriers for medical use, lipid nanoparticles for delivering drugs; lipid nanoparticles for drug delivery sold as an integral component of drugs; pharmaceutical preparations, messenger RNA and delivery agents comprised of lipid nanoparticle carriers and polymers for the delivery of mRNA to human cells;IMMUNE ECHO;Medical, biological, and pharmaceutical preparations for scientific, research, medical laboratory use, or for the manufacture of pharmaceuticals, preparations containing messenger RNA for preventing and treating viruses and respiratory disorders; biochemicals for in vivo, ex vivo, on vivo or in vitro scientific research and medical research, for use in the manufacture of pharmaceuticals for preventing and treating viruses and respiratory disorders; lipid nanoparticles for scientific, laboratory or medical research use;Medical services; medical information; providing a website featuring medical information;Pharmaceutical research and development; medical research services; biotechnology research; scientific research for medical purposes; design and development of medical technology; design, engineering, research, and development services in the field of nucleic acid sciences for medical and scientific applications; providing medical and scientific research in the fields of pharmaceuticals and vaccines;
Categories: VACCINES